You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
Colorcon
Moodys
Harvard Business School
Mallinckrodt

Last Updated: February 26, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Meso-Erythritol


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

What is the drug development status for Meso-Erythritol?

Meso-Erythritol is an investigational drug.

There have been 19 clinical trials for Meso-Erythritol. The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2018.

The most common disease conditions in clinical trials are Mesothelioma, Neoplasms, Glandular and Epithelial, and Malaria. The leading clinical trial sponsors are Hrain Biotechnology Co.,Ltd., Stony Brook University, and Chinese University of Hong Kong.

There is one US patent protecting this investigational drug and nineteen international patents.

Recent Clinical Trials for Meso-Erythritol
TitleSponsorPhase
Evaluation of the Implementation and Effectiveness of Intermittent Preventive Treatment for Malaria Using Dihydroartemisinin-piperaquine on Reducing Malaria Burden in School Aged Children in TanzaniaNational Malaria Control Program, TanzaniaPhase 4
Evaluation of the Implementation and Effectiveness of Intermittent Preventive Treatment for Malaria Using Dihydroartemisinin-piperaquine on Reducing Malaria Burden in School Aged Children in TanzaniaNational Institute for Medical Research, TanzaniaPhase 4
BEAT-meso: Bevacizumab and Atezolizumab in Malignant Pleural MesotheliomaHoffmann-La RochePhase 3

See all Meso-Erythritol clinical trials

Clinical Trial Summary for Meso-Erythritol

Top disease conditions for Meso-Erythritol
Top clinical trial sponsors for Meso-Erythritol

See all Meso-Erythritol clinical trials

US Patents for Meso-Erythritol

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Meso-Erythritol   Start Trial Aqueous foaming composition and method for homogenizingly incorporating water into lipophilic materials Battelle Memorial Institute (Carouge, CH)   Start Trial
Meso-Erythritol   Start Trial Silver halide color photographic material having improved dye image stability Fuji Photo Film Co. Ltd. (Tokyo, JP)   Start Trial
Meso-Erythritol   Start Trial Anti-clumping agents for expandable vinylaromatic-acrylonitrile polymeric materials The Dow Chemical Company (Midland, MI)   Start Trial
Meso-Erythritol   Start Trial Process for preparing partial polyol fatty acid esters Van den Bergh Foods Co., Division of Conopco Inc. (New York, NY)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Meso-Erythritol

Drugname Country Document Number Estimated Expiration Related US Patent
Meso-Erythritol Austria 82672 2007-06-26   Start Trial
Meso-Erythritol Canada 1317506 2007-06-26   Start Trial
Meso-Erythritol Switzerland 672996 2007-06-26   Start Trial
Meso-Erythritol Germany 3876151 2007-06-26   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Mallinckrodt
McKesson
McKinsey
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.